PYCARD and glioblastoma: Consistent with the result of immunohistochemistry, PYCARD was significantly up-regulated in human KIRC cells (CaKi-1), GBM cells (U87 MG and T98G), and PAAD cells (ASPC-1 and PANC-1) (Fig. 3D–F).